Abnormal Uterine Bleeding in Adolescent Women

被引：0
作者：
Mullins E.S. [1 ,2 ]
Miller R.J. [3 ,4 ]
Mullins T.L.K. [2 ,5 ]
机构：
[1] Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, 45229, OH
[2] University of Cincinnati College of Medicine, CARE/Crawley Building, Suite E-870, 3230 Eden Avenue, Cincinnati, 45267, OH
[3] Pediatric and Adolescent Gynecology, Children’s Hospitals and Clinics of Minnesota, Minneapolis, 55404, MN
[4] Department of Obstetrics, Gynecology and Women’s Health, University of Minnesota, Minneapolis, 55455, MN
[5] Division of Adolescent and Transition Medicine, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Ave, MLC 4000, Cincinnati, 45229, OH
来源：
Current Pediatrics Reports | 2018年 / 6卷 / 2期
关键词：
Abnormal uterine bleeding; Adolescent; Bleeding disorder evaluation; Heavy menstrual bleeding;
D O I：
10.1007/s40124-018-0164-9
中图分类号：
学科分类号：
摘要：
Purpose of Review: To review the current state of terminology, evaluation, and management of abnormal uterine bleeding (AUB) in adolescents. Recent Findings: The current terminology classifies the causes of AUB under the mnemonic “PALM-COEIN”: Polyps, Adenomyosis, Leiomyoma, Malignancy/hyperplasia; Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not yet classified. Heavy menstrual bleeding (HMB) is one manifestation of AUB. Complete menstrual, gynecologic, medical, and family histories, together with a thorough physical exam, are critical to the determination of the underlying cause of AUB. Initial laboratory testing should be guided by the findings of history and physical. Hormonal therapy is the mainstay of acute and chronic management of AUB. Hemostatic treatments could be considered. Summary: The primary management for AUB is with hormonal medications. Further studies of combining estrogen-containing hormonal management and hemostatic therapies (such as tranexamic acid) are needed given the theoretical concerns about increased risk of thromboembolism in women with difficult to manage AUB. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码：123 / 131
页数：8
相关论文
共 94 条
  • [1] Munro M.G., Critchley H.O., Broder M.S., Fraser I.S., FIGO working group on menstrual disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age, Int J Gynaecol Obstet, 113, 1, pp. 3-13, (2011)
  • [2] ACOG committee opinion no. 557: management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women, Obstet Gynecol, 121, 4, pp. 891-896, (2013)
  • [3] ACOG Committee Opinion No. 651: menstruation in girls and adolescents: using the menstrual cycle as a vital sign, Obstet Gynecol, 126, 6, pp. e143-e146, (2015)
  • [4] Hallberg L., Hogdahl A.M., Nilsson L., Rybo G., Menstrual blood loss and iron deficiency. Acta Med Scand. 1966
  • [5] 180(5):639-50. As cited in Bitzer J., Heikinheimo, O., Nelson, A., et al. Medical management of heavy menstrual bleeding: a comprehensive review of the literature, Obstet Gynecol Survey, 70, pp. 115-130, (2015)
  • [6] Bitzer J., Heikinheimo O., Nelson A.L., Calaf-Alsina J., Fraser I.S., Medical management of heavy menstrual bleeding: a comprehensive review of the literature, Obstet Gynecol Surv, 70, 2, pp. 115-130, (2015)
  • [7] Munro M.G., Critchley H.O., Fraser I.S., The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them?, Am J Obstet Gynecol, 207, 4, pp. 259-265, (2012)
  • [8] Warner P.E., Critchley H.O., Lumsden M.A., Campbell-Brown M., Douglas A., Murray G.D., Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data, Am J Obstet Gynecol, 190, 5, pp. 1216-1223, (2004)
  • [9] Higham J.M., O'Brien P.M., Shaw R.W., Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990
  • [10] 97(8):734-9
12345678910